New Jersey needs turnkey lab space, faster approvals to compete for life sciences users

Experts say New Jersey faces a growing challenge: While it’s still a major draw for pharmaceutical research and development, speed to market has become increasingly important to life sciences users. That means the state’s lack of move-in-ready lab space — and its lengthy approval process for new construction — puts it at a disadvantage to competing markets.

Thor kicks off construction to create new lab, R&D building in Jersey City, JLL says

Thor Equities has started construction in its plan to overhaul a 350,000-square-foot building in Jersey City, where it aims to create “lab-ready” space that will attract life sciences users.

JLL details $95 million sale of Jersey City building, now slated to become life sciences hub

Thor Equities Group is eyeing plans to reposition a historic building in Jersey City into research and laboratory space, following its recent acquisition of the nearly 340,000-square-foot property.

SJP rebrands Jersey City office building, targets science and tech users

SJP Properties has rebranded an office building in downtown Jersey City with an eye toward emerging and specialized industries, tapping JLL as the property’s leasing agent.